Evaluation of cancer treatment in the abdomen: Trends and advances

Figure 5 A computed tomography image of a 22-year-old female with Hodgkin’s lymphoma after 4 cycles of chemotherapy demonstrated residual mediastinal lymphadenopathy (A) that is not metabolically active, as seen on positron emission tomography/computed tomography fusion images, and consistent with post-therapy fibrosis (B). A computed tomography image of a 50-year-old male with diffuse large B-cell lymphoma after 6 cycles of chemotherapy showed a residual mediastinal abnormality that represents viable tumor as shown by the abnormal actiivty on the positron emission tomography/computed tomography fusion image. Also note left pleural effusion and bone marrow activation (D).